BIOMAT Database Logo BIOMAT Database Logo

[Chemotherapy of a patient with FIGO stage IV vulvar cancer with bleomycin, vincristine, mitomycin C, and cisplatin]. 1989

Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Department of Gynecology, Cancer Institute Hospital, Tokyo.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine

Related Publications

Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
[Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
March 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
February 1987, Gynecologic oncology,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
[A case of FIGO stage IV A vulvar cancer successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)].
July 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP).
January 1980, Cancer treatment reports,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
[A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
March 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer.
August 1978, Obstetrics and gynecology,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
March 1985, Gynecologic oncology,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
[Combination chemotherapy of peplomycin, vincristine, mitomycin C, and cisplatin in gynecologic carcinomas].
August 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Neoadjuvant chemotherapy in bulky stage IB-IIA cervical cancer: results of a quick course with vincristine, bleomycin, and cisplatin.
January 2009, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Y Shimizu, and K Hasumi, and H Yagi, and K Nakayama, and J T Chen, and Y Hirai, and T Hamada, and I Fujimoto, and K Yamauchi, and K Masubuchi
Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
May 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!